Provided by Tiger Trade Technology Pte. Ltd.

Nasus Pharma Ltd.

7.33
+0.718110.86%
Post-market: 7.330.00000.00%16:04 EST
Volume:1.78K
Turnover:12.35K
Market Cap:66.42M
PE:-33.62
High:7.33
Open:6.75
Low:6.63
Close:6.61
52wk High:9.99
52wk Low:5.90
Shares:9.06M
Float Shares:3.98M
Volume Ratio:2.76
T/O Rate:0.04%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.2180
EPS(LYR):-0.2180
ROE:--
ROA:-116.06%
PB:-20.68
PE(LYR):-33.62

Loading ...

Company Profile

Company Name:
Nasus Pharma Ltd.
Exchange:
NASDAQ
Establishment Date:
2019
Employees:
2
Office Location:
Yigal Alon 65,Tel Aviv-Yafo,Israel
Zip Code:
6744317
Fax:
- -
Introduction:
- -

Directors

Name
Position
Dan Teleman
Chief Executive Officer, Director
Udi Gilboa
Co-Founder and Executive Chairman of the Board
Dalia Megiddo
Co-Founder, Director, Chief Development Officer and Chief Medical Officer
David Silberman
Director
Isaac Israel
Director
Ronnie Hershman
Director
Sharon Shacham
Director

Shareholders

Name
Position
Dan Teleman
Chief Executive Officer, Director
Eyal Rubin
Executive Vice President and Chief Financial Officer
Dalia Megiddo
Co-Founder, Director, Chief Development Officer and Chief Medical Officer
Galia Temtsin Kryaz
Director of CMC and Product Development
Oren Elmaliach
Director of Finance
Tair Lapidot
Vice President of Research and Development and Clinical Development
Udi Gilboa
Co-Founder and Executive Chairman of the Board